Risk of Domestic Market Contraction Due to the Declining Birthrate, Aging Population and Population Decline
First written in FY2020. 5 of 6 entries say "Worsened", first in FY2022. Latest entry: FY2026.
Ichimasa Kamaboko moved to the "Worse" side of this theme in 2022, 1 year before the typical company in this theme (2023).
The whole theme swung hardest in 2023: 10 of 30 companies on the "Worse" side.
9 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「The number of births in Japan fell for the 10th consecutive year in 2025 to a record low of 670,000, while the birth rate fell to 1.14, also setting a new record low. The aging population and declining birth rate are accelerating, and the domestic market is expected to face a more challenging business environment than before.」
It presents the latest figures of 670,000 births and a birth rate of 1.14, and describes the worsening risk of domestic market contraction due to the aging population, declining birth rate and population decline. - FY2025WorsenedAnnual report
「The number of births and the birth rate in Japan declined for the ninth consecutive year in 2024. The number of births reached a record low of approximately 680,000, falling into the 600,000 range for the first time, while the total fertility rate also reached a record low of 1.15. The aging population and declining birth rate are accelerating, and the domestic market is expected to face a more challenging business environment than before.」
It notes that the number of births reached a record low of approximately 680,000 and the total fertility rate fell to 1.15, and describes the worsening risk of domestic market contraction due to the aging population, declining birth rate and population decline. - FY2024WorsenedAnnual report
「The number of births in Japan fell for the eighth consecutive year in 2023 to a record low in the 720,000 range. While government measures to address the declining birth rate have yet to produce noticeable results, the domestic market is expected to face a more challenging business environment than before amid the advancing aging of the population and other factors.」
It indicates that the number of births in Japan reached a record low in the 720,000 range and recognizes that the domestic market is becoming even more challenging due to the aging population, declining birth rate and population decline. - FY2023WorsenedAnnual report
「The number of births in Japan in 2022 fell below the 2021 record low, dropping below 800,000 for the first time. The declining birth rate is accelerating, and the domestic market is expected to face a more challenging business environment than before, together with the aging population and other factors.」
It indicates that the number of births in Japan fell below 800,000 for the first time and recognizes that the domestic market environment will become more challenging than before due to the aging population, declining birth rate and population decline. - FY2022WorsenedAnnual report
「The declining birth rate is accelerating, with the number of births in fiscal 2021 reaching a record low, and the domestic market is expected to face a more challenging business environment than before due to the aging population, population decline and other factors.」
It states that the domestic market will face a more challenging environment than before due to the accelerating decline in the birth rate, the aging population and the population decline. - FY2020First statedAnnual report
「Japan's market is tending to contract over the long term as the declining birth rate and aging population continue. Against this backdrop, a substantial economic downturn or the obsolescence of our Group's products and a decline in market share resulting from new products or sales-promotion activities by competitors could affect the Group's business results and financial position.」
The long-term contraction of the domestic market due to the declining birth rate, aging population and population decline, together with product obsolescence and market-share declines caused by competitors, is identified as a standalone risk for the first time.